Professor Eliot Forster
chief executive officer, Levicept; non-executive chairman, Protalix; honorary visiting professor, University of Liverpool and University of Pavia

Eliot has more than three decades of experience in the pharmaceutical and biotechnology industry, having co-founded and lead several companies. He is chief executive officer of Levicept and is non-executive chairman of Protalix (NYSE PLX) and non-executive director of Immatics NV (NASDAQ IMTX).

He is an honorary visiting professor of molecular and clinical cancer medicine at the University of Liverpool and an honorary international visiting professor at the University of Pavia, Italy. He holds a PhD from University of Liverpool and an MBA from Henley Management College. Eliot hosts the podcast The Life Sci Fantastic.

RELATED SESSIONS

Saturday 17 October, 10:15 Harvey Goodwin Suite, Church House
Podcast Live: The Life Sci Fantastic – weight-loss jabs: the end of willpower?